Shifting the lines against central nervous system disorders
  • [Corporate] Home Banner

Please enter the email address associated with your User account. Your username will be emailed to the email address on file.

THERANEXUS reports cash position as of September 30th 2019

Download PDF File (285 Ko)

THERANEXUS announces its first half 2019 results

Download PDF File (285 Ko)

A new milestone reached for Theranexus: inclusion of last patient in phase II trial for THN102 in Parkinson’s patients

Download PDF File (285 Ko)

THERANEXUS announces inclusion of last subject in its phase 1b trial of THN201

Download PDF File (397 Ko)

THERANEXUS announces the publication of two scientific papers and a presentation at the European pain congress (EFIC) to be held on 3-7 September in Valencia, Spain

Download PDF File (393 Ko)

December, 2019 : CF&B Midcap Event, Geneva (exact date to be confirmed)